Citius Pharmaceuticals, Inc. (CTXR): Insider Trading, Congress Trades & Research | Tormere

CTXR

$0.55-3.87%visit website

Citius Pharmaceuticals, Inc.

Market Cap

$15M

Live price × SEC shares (Aug 13, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

1.02

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Sep 30, 2025	Q1 FY2026 Dec 31, 2025	Q2 FY2026 Mar 31, 2026	Q3 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue		3,944	1,667	1,494
Cost of revenue		789	329	492
Gross profit		3,155	1,338	1,002
Research & development	1,642	1,600	1,634	1,054	5,929
Total operating expenses	8,437	12,174	33,533	12,734	66,879
Operating income	(8,437)	(9,019)	(32,195)	(11,732)	(61,383)
Interest expense	96	156	33	198	482
Pretax income	(8,479)	(9,130)	(28,341)	(12,027)	(57,977)
Income tax	264	264	(231)	(107)	190
Net income	(7,959)	(8,221)	(21,231)	(8,863)	(46,274)
EPS (basic) ($)		(0.38)	(0.95)	(0.34)	—
EPS (diluted) ($)		(0.38)	(0.95)	(0.34)	—
Weighted avg. shares (basic)		21,495	22,376	26,170
Weighted avg. shares (diluted)		21,495	22,376	26,170

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 14, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 59 more quarters, back to Dec 2010, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

14

recent articles

No Form 4 transactions on record.

Recent News

Citius Pharmaceuticals to Participate in October 2026 Investor Conferences

Yahoo Finance · 2026-10-12

Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri

Yahoo Finance · 2026-08-12

CTXR Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-25

Is Citius Pharmaceuticals, Inc. (CTXR) among the Best Rated Penny Stocks to Buy According to Wall Street Analysts?

Yahoo Finance · 2026-05-24

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

Yahoo Finance · 2026-04-24

Citius Pharmaceuticals Secures $5M Through Equity Offering

Yahoo Finance · 2026-04-24

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

Yahoo Finance · 2026-04-24

What's Behind The Drop In Citius Pharmaceuticals? - Citius Pharmaceuticals (NASDAQ:CTXR)

Benzinga · 2026-04-24

We Might See A Profit From Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Soon

Yahoo Finance · 2026-04-21

Citius Oncology Provides Commercial Update on LYMPHIR™ Launch Highlighting Early Adoption and Expanding Clinical Development

Yahoo Finance · 2026-03-31

symbol__ Stock Quote Price and Forecast

CNN · 2024-01-12

Citius Pharmaceuticals Stock Price Forecast. Should You Buy CTXR?

StockInvest.us · 2020-12-01

CITIUS PHARMACEUTICALS INC (CTXR) Stock Price & Overview

ChartMill · 2019-12-21

Citius Pharmaceuticals (CTXR)

Zacks Investment Research · 2017-09-16

Informational purposes only, not investment advice.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Nov 4, 2026 accepted 4:30 PM ET	8.01Other events	SEC ↗
Oct 26, 2026 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗